# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Exact Sciences said first-quarter revenue increased 6% year-over-year to $638 million, which beat the consensus estimate of $62...
Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0....
Wednesday witnessed a tempering of the bullish sentiment that had buoyed Wall Street in recent sessions, with major indices sho...
U.S. stocks are on track for a mixed start on Wednesday as the market digests mixed earnings reports and looks ahead to more sp...
According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far.
To help facilitate a smooth transition, Bloomer joins the company as executive vice president, finance, effective immediately, ...
On April 10, 2024 it entered into privately negotiated exchange and purchase agreements (the "Agreements") with certain...